These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 9857974

  • 1. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH.
    Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
    [Abstract] [Full Text] [Related]

  • 2. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 3. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H.
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [Abstract] [Full Text] [Related]

  • 4. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.
    El-Agnaf OM, Curran MD, Wallace A, Middleton D, Murgatroyd C, Curtis A, Perry R, Jaros E.
    Neuroreport; 1998 Dec 01; 9(17):3925-7. PubMed ID: 9875730
    [Abstract] [Full Text] [Related]

  • 5. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.
    Mov Disord; 2004 Feb 01; 19(2):162-70. PubMed ID: 14978671
    [Abstract] [Full Text] [Related]

  • 6. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG, Goedert M.
    Ann N Y Acad Sci; 2000 Feb 01; 920():16-27. PubMed ID: 11193145
    [Abstract] [Full Text] [Related]

  • 7. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA.
    Exp Neurol; 1998 Dec 01; 154(2):684-90. PubMed ID: 9878203
    [Abstract] [Full Text] [Related]

  • 8. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S, Arai H, Matsushita S, Matsui T, Kimpara T, Takeda A, Shirakura K.
    Exp Neurol; 1998 Sep 01; 153(1):164-6. PubMed ID: 9743579
    [Abstract] [Full Text] [Related]

  • 9. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.
    Trojanowski JQ, Lee VM.
    Arch Neurol; 1998 Feb 01; 55(2):151-2. PubMed ID: 9482355
    [No Abstract] [Full Text] [Related]

  • 10. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H, Sandmann-Keil D, Gai W, Braak E.
    Neurosci Lett; 1999 Apr 09; 265(1):67-9. PubMed ID: 10327208
    [Abstract] [Full Text] [Related]

  • 11. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA.
    Acta Neuropathol; 2003 Sep 09; 106(3):191-201. PubMed ID: 12845452
    [Abstract] [Full Text] [Related]

  • 12. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov 09; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 13. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR, Simpson JE, Watson LC, Mortiboys H, Hautbergue GM, Bandmann O, Highley JR.
    Brain Res; 2019 Mar 01; 1706():218-223. PubMed ID: 30267647
    [Abstract] [Full Text] [Related]

  • 14. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 01; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 15. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K, Takahashi H.
    Nihon Rinsho; 2000 Oct 01; 58(10):2022-7. PubMed ID: 11068441
    [Abstract] [Full Text] [Related]

  • 16. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.
    Brain Res; 1999 Oct 02; 843(1-2):53-61. PubMed ID: 10528110
    [Abstract] [Full Text] [Related]

  • 17. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y.
    J Neural Transm Suppl; 2000 Oct 02; (60):101-16. PubMed ID: 11205133
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.
    Crowther RA, Daniel SE, Goedert M.
    Neurosci Lett; 2000 Oct 06; 292(2):128-30. PubMed ID: 10998565
    [Abstract] [Full Text] [Related]

  • 19. alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.
    Gómez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT.
    Acta Neuropathol; 2000 Apr 06; 99(4):352-7. PubMed ID: 10787032
    [Abstract] [Full Text] [Related]

  • 20. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.
    Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE.
    Neurology; 2000 May 23; 54(10):1916-21. PubMed ID: 10822429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.